-+ 0.00%
-+ 0.00%
-+ 0.00%

PHARVARIS's phase 3 clinical trial reached all major and secondary endpoints.

Zhitongcaijing·09/08/2026 10:57:03
Listen to the news
PHARVARIS's phase 3 clinical trial reached all major and secondary endpoints.